Published in Law and Health Weekly, January 14th, 2006
Researchers in Russia and the Netherlands conducted a study "to evaluate the antitumor effect of mouse immunization with human mucin 1 gene (muc1) DNA plasmids combined with simultaneous injections of human mucin I (MUC1) protein."
"MUC1 DNA was cloned in pBK-CMV to prepare DNA plasmids and in pET22b+ to produce proteins. Three strains of mice, immunized with DNA or DNA plus MUC1, were inoculated with tumor cells obtained from spontaneous tumors. IgG2a , production, MUC1-specific IFN-gamma-producing CD8+ T cells, tumor growth and mouse survival were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.